Efforts have been made to develop therapeutic approaches targeting ADRB3 to treat or prevent obesity and metabolic disorders, and CL-316243 has been used for generating brown-like adipocytes in WAT17, 38. This evidence concerns the gene ADRB3 and metabolic disease.